mTOR activity is also elevated in renal endothelial cells of lupus patients and mice (Mao et al., 2022; Huang et al., 2024) and could serve as a biomarker and predictor of disease progress in lupus nephritis (Mao et al., 2022). This evidence concerns the gene MTOR and systemic lupus erythematosus.